The Abortion Pill's Exile in Obscurity
Listen to the Story - Un pódcast de Bloomberg
Categorías:
Twenty-one years after its approval by the FDA, mifepristone could—but probably won’t— revolutionize a post-Roe world. By Cynthia KoonsSee omnystudio.com/listener for privacy information.
